CME Symposium - Optimizing Clinical Outcomes in Acute Coronary Syndromes: Exploring Best Practices

A CME Satellite Program taking place Sunday, November 17, 2013 at the 2013 American Heart Association from 6:30PM - 9:00PM at the Omni Dallas Hotel, Dallas Ballroom, E, F, G; 555 S. Lamar, Dallas, Texas.
 
 
2013 CME Symposium AHAZ
2013 CME Symposium AHAZ
 
Spread the Word
Listed Under

Tags:
* Cme
* Continuing Medical Education
* American Heart Association

Industrys:
* Education
* Health

Location:
* Dallas - Texas - US

Subject:
* Events

DALLAS - Sept. 25, 2013 - PRLog -- Dual oral antiplatelet therapy, with aspirin and a P2Y12 receptor inhibitor, for the management of patients experiencing an acute coronary syndrome (ACS), has demonstrated significant improvements in the prevention of recurring major cardiovascular events versus aspirin alone. Clopidogrel, prasugrel, and ticagrelor are three P2Y12 receptor inhibitors, with distinct pharmacologic properties, used in the management of ACS, and all three have been studied in large cardiovascular outcome clinical trials. Both prasugrel and ticagrelor have been studied separately against clopidogrel, on a background of aspirin therapy, in the setting of ACS. These landmark trials had distinct trial designs, and the study results have led to the inclusion of prasugrel and ticagrelor in ACS clinical practice guidelines. With the arrival of these newer agents, clinicians now face more complex choices regarding selection of clopidogrel, prasugrel, or ticagrelor to accompany aspirin therapy in ACS management. In this program, Chair Dr. Gregg Stone and faculty members Dr. Christopher Cannon, Dr. James de Lemos, Dr. Cindy Grines, Dr. Paul Gurbel, and Dr. P. Gabriel Steg, will provide attendees with state-of-the-art information on these agents in the settings of unstable angina/NSTEMI and STEMI, and debate and recommend best strategies in challenging ACS cases.

Sunday, November 17, 2013

Register online at: http://www.symposiareg.com/21311
Walk-Ins are welcome*

Registration and Buffet Dinner: 6:30 PM - 7:00 PM
Symposium: 7:00 PM - 9:00 PM

Dallas Ballroom E, F, G
Omni Dallas Hotel
555 S. Lamar
Dallas, Texas

Chair
Gregg Stone, MD
Professor of Medicine
Columbia University
New York, New York

Faculty
Christopher Cannon, MD
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

James de Lemos, MD
Professor of Medicine
University of Texas Southwestern Medical School
Dallas, Texas

Cindy Grines, MD
Professor of Medicine
Wayne State University
Detroit, Michigan

Paul Gurbel, MD
Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

P. Gabriel Steg, MD
Professor of Cardiology
Universite Paris-Diderot
Paris, France

Click Here to Register (http://www.symposiareg.com/21311)

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Supported by an educational grant from AstraZeneca Pharmaceuticals, LP.

This event is not part of the official Scientifc Sessions 2013 as planned by the AHA Committee on Scientifc Sessions Programming

.

Pre-registration is for planning purposes only.
For additional CME activities and online cme courses visit http://www.cmeplanet.com
End
Source:Voxmedia LLC
Email:***@voxmedia.us Email Verified
Phone:973-467-0500
Tags:Cme, Continuing Medical Education, American Heart Association
Industry:Education, Health
Location:Dallas - Texas - United States
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Voxmedia News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share